Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor
Authors:
Open Access
- 1 October 2015
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 8, 3079-3086
Abstract
Transarterial oily chemoembolization (TOCE) is one of the most effective approaches for the treatment of patients with hepatocellular carcinoma (HCC), who are not suitable for surgical therapy. Lidamycin (LDM), a potent antitumor antibiotic, demonstrates good antitumor efficacy in various tumor types, both in vitro and in vivo. In this study, the antitumor efficacy of LDM combined with TOCE against the rabbit VX2 tumor was assessed. A toxicity assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) demonstrated that a combination of LDM with lipiodol did not impair the cytotoxicity of LDM against HepG2 cells in vitro. Using TOCE in rabbit VX2 tumor models, LDM showed a more powerful inhibitory effect against the tumor and lowered the expression levels of proliferating cell nuclear antigen (PCNA), cluster of differentiation 31 (CD31), and vascular endothelial growth factor (VEGF) compared to Adriamycin (ADM); moreover, this improvement was not accompanied by an increase of hepatotoxicity as shown by alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. These results suggested that LDM combined with TOCE may be a feasible strategy in HCC therapy in the future.Keywords
This publication has 25 references indexed in Scilit:
- Hepatocellular carcinoma epidemiologyBest Practice & Research Clinical Gastroenterology, 2014
- Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work reviewHepatology Research, 2014
- Hepatocellular carcinoma: A comprehensive overview of surgical therapyJournal of Surgical Oncology, 2014
- Advances in non-surgical management of primary liver cancerWorld Journal of Gastroenterology, 2014
- Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.2013
- Evaluation of current practiceAnti-Cancer Drugs, 2011
- The Treatment Responses in Cases of Radiation Therapy to Portal Vein Thrombosis in Advanced Hepatocellular CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapiesCancer Treatment Reviews, 2006
- Management of Hepatocellular CarcinomaJournal of Gastrointestinal Surgery, 2006
- Large Liver Tumors: Protocol for Radiofrequency Ablation and Its Clinical Application in 110 Patients—Mathematic Model, Overlapping Mode, and Electrode Placement ProcessRadiology, 2004